Drug intelligence / Profile preview

nitrendipine + hydrochlorothiazide

Development stage
Unknown
Lead developer
Bayer
Modality
Small Molecules
Administration
Oral
01

Overview

Nitrendipine + hydrochlorothiazide is a fixed-dose combination of two antihypertensive agents used for the treatment of hypertension. Nitrendipine is a dihydropyridine calcium channel blocker that acts as a peripheral vasodilator by inhibiting the influx of extracellular calcium across myocardial and vascular smooth muscle cell membranes, leading to decreased vascular resistance and blood pressure[5][8]. Hydrochlorothiazide is a thiazide diuretic that reduces blood pressure by increasing renal excretion of sodium and water, thereby decreasing plasma volume[2][3][4]. The combination provides additive antihypertensive effects compared to either agent alone, making it effective in patients who require more than one medication to achieve blood pressure control[8].

02

Targets

SLC12A3 (Thiazide-sensitive sodium-chloride cotransporter)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)

Beyond the preview

Go deeper on nitrendipine + hydrochlorothiazide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nitrendipine + hydrochlorothiazide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call